To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting Conditions
NCT ID: NCT00946764
Last Updated: 2017-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
48 participants
INTERVENTIONAL
2005-07-31
2005-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults
NCT06705569
Bioequivalency Study of Protriptyline 10 mg Tablets Under Fasted Conditions
NCT00754962
A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fasting Conditions
NCT00865085
Bioequivalence Study of Topiramate Tablets 25mg Under Fed Conditions
NCT00902473
Topiramate 25 mg Capsules Under Fed Conditions
NCT00904943
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Imipramine Hydrochloride 50 mg Tablets (Sandoz Inc.)
Imipramine Hydrochloride 50 mg Tablets (Sandoz Inc.)
2
Tofranil Imipramine Hydrochloride 50 mg Tablets (Tyco Healthcare)
Tofranil Imipramine Hydrochloride 50 mg Tablets (Tyco Healthcare)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Imipramine Hydrochloride 50 mg Tablets (Sandoz Inc.)
Tofranil Imipramine Hydrochloride 50 mg Tablets (Tyco Healthcare)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Treatment for drug or alcohol dependence.
19 Years
54 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sandoz
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sandoz Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gaetano Morelli, M.D.
Role: PRINCIPAL_INVESTIGATOR
MDS Pharma Services
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AA28312
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.